Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Myriad Genetics Inc MYGN

Healthcare Biotechnology
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. The Company is focused on three key areas where it has... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:MYGN)

Survey Suggests Increased Attention on Mental Health Warranted in the Run-Up to the Election

GlobeNewswire 1 day ago

Myriad Genetics Collaborates with GSK to Improve Access to HRD Testing in 9 Countries

GlobeNewswire June 11, 2024

Myriad Genetics Launches New Universal Plus Panel for Foresight® Carrier Screen

GlobeNewswire June 4, 2024

Genetics in Medicine Publishes Myriad Genetics Patient-Outcomes Study Validating RiskScore® as a Clinical Breast Cancer Risk Assessment Tool

GlobeNewswire June 3, 2024

Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting

GlobeNewswire May 23, 2024

New Study Published in JCO Precision Oncology Shows Myriad Genetics' Prolaris Test Can Predict Benefit of Hormone Therapy Treatment in Men with Localized Prostate Cancer

GlobeNewswire May 16, 2024

Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA

GlobeNewswire May 7, 2024

Myriad Genetics Announces Reorganization of European Operations and Sale of EndoPredict Business

GlobeNewswire May 7, 2024

Myriad Genetics to Release First Quarter 2024 Financial Results on May 7, 2024

GlobeNewswire April 30, 2024
View More News ››

Opinion & Analysis (NDAQ:MYGN)

Myriad Genetics Shares Fall 30% on Q2 Earnings and Executive Leadership Change

Streetwise Reports February 10, 2020

This company's loss is your gain

Marc Lichtenfeld June 19, 2013

Stock pick in cancer genetics testing

Michael Cintolo December 23, 2008
View More Opinion ››

Bullboard Posts (NDAQ:MYGN)

4 STOCKS OPENING NEW FRONTIERS IN WOMEN’S HEALTH!

$MYGN $SERA $PGNY $MYOV   8th March celebrates the cultural, political and socioeconomic achievements of women ...
AviseAnalytics - March 8, 2022

Myriad Genetics Inc. Options

On 01/12/09 Myriad Genetics Inc. options ( MYGN ) are used as an example of market neutral investing on PERSONALHEDGEFUNDS.COM. Hedge...
nickmessaro02 - January 10, 2009

MYGN is seen possible buy by Chartplays.com

MYGN is reviewed as the focus free chart of the day at Chartplays.com today. According to the folks at Chartplays.com, MYGN is showing...
battlinal74 - August 16, 2002

Target Acquire Price $16

Anyone have any opinions? Great balance sheet, but drastically overpriced.
0379 - May 7, 2002

Genomics Execs Aren’t Worried

Ignore the bears, genomics bulls say. Advancements in medicine are coming and companies that understand genes are the ones that will make...
SCCNewsServices - April 17, 2000
View more Bullboard ››

Lithium Ionic Corp

Lithium Ionic Corp

Lithium Ionic Corp. is a Canadian mining company. The Company is engaged exploring and developing its lithium properties in ...
View More »